<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A number of systemic disorders increase patient susceptibility to <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e>, which moreover evolves more rapidly and more aggressively </plain></SENT>
<SENT sid="1" pm="."><plain>The underlying factors are mainly related to alterations in immune, <z:chebi fb="32" ids="24621">endocrine</z:chebi> and connective tissue status </plain></SENT>
<SENT sid="2" pm="."><plain>These alterations are associated with different pathologies and syndromes that generate <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e> either as a primary manifestation or by aggravating a pre-existing condition attributable to local factors </plain></SENT>
<SENT sid="3" pm="."><plain>This is where the role of <z:mp ids='MP_0001794'>bacterial</z:mp> plaque is subject to debate </plain></SENT>
<SENT sid="4" pm="."><plain>In the presence of qualitative or quantitative cellular immune alterations, <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e> may manifest early on a severe localized or generalized basis--in some cases related to the presence of plaque and/or specific bacteria (severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> or infantile genetic <z:mp ids='MP_0000334'>agranulocytosis</z:mp>, Chediak-Higiashi <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">syndrome, Down</z:e> syndrome and Papillon-Lefévre syndrome) </plain></SENT>
<SENT sid="5" pm="."><plain>In the presence of humoral immune alterations, periodontal damage may result indirectly as a consequence of alterations in other systems </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e>, <z:mp ids='MP_0001794'>bacterial</z:mp> plaque and alterations of the periodontal tissues increase patient susceptibility to gingival <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C0002382" disease_type="Disease or Syndrome" abbrv="">alveolar resorption</z:e> (<z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehler-Danlos syndrome</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>The management of <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e> focuses on the control of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:mp ids='MP_0001794'>bacterial</z:mp> plaque by means of mechanical and chemical methods </plain></SENT>
<SENT sid="8" pm="."><plain>Periodontal surgery and even extraction of the most seriously affected teeth have also been suggested </plain></SENT>
<SENT sid="9" pm="."><plain>There are variable degrees of consensus regarding the background systemic disorder, as in the case of Chediak-Higiashi syndrome, where antibiotic treatment proves ineffective; in severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> or infantile genetic <z:mp ids='MP_0000334'>agranulocytosis</z:mp>, where antibiotic prophylaxis is suggested; and in Papillon-Lefévre syndrome, where an established treatment protocol is available </plain></SENT>
</text></document>